Epithelial ovarian cancer is the gynecological tumor with the highest mortality rate. Recently, numerous new findings have emerged about status and extent of surgical therapy of this disease. Innovations regarding chemotherapy are also numerous. It is essential for the improvement of the patients' situation to transfer these new developments already implemented into national and international standards and guidelines to clinical practice.